Form 4: Doximity Director Sells Shares Under 10b5-1 Plan

A Doximity director exercised stock options and sold Class A Common Stock shares on December 1, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Kira Scherer Wampler, a Director at Doximity, Inc., reported transactions on December 1, 2025.
• Exercised stock options to acquire 2,000 shares of Class B Common Stock at an exercise price of $1.54 per share.
• Converted these 2,000 shares of Class B Common Stock into 2,000 shares of Class A Common Stock.
• Sold 2,000 shares of Class A Common Stock at a price of $50.71 per share.
• These sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024.
• Following these transactions, the reporting person beneficially owns 19,839 shares of Class A Common Stock and 462,700 stock options for Class B Common Stock.

Sentiment

Score: 5

Explanation: The transactions represent a routine exercise of vested stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan. While it involves an insider selling shares, the pre-planned nature mitigates any negative signal typically associated with insider selling, resulting in a neutral sentiment.

Positives

• The exercise of stock options indicates the director is realizing value from previously granted equity compensation.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, demonstrating adherence to insider trading compliance protocols and transparency.

Negatives

• A director selling shares reduces their direct ownership stake in the company.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale of shares by a director slightly reduces insider ownership, but the pre-planned nature of the transaction under a Rule 10b5-1 plan minimizes concerns about its implications for company prospects or future performance.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction involving the exercise of vested stock options and the subsequent sale of a portion of the resulting shares under a Rule 10b5-1 trading plan. Such pre-scheduled transactions are common for executives and directors to manage their equity compensation and personal finances. They typically do not signal new information about the company's performance or future outlook, thus warranting a 'hold' recommendation as this filing alone does not provide a basis for a change in investment thesis.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Director Transaction, Equity Compensation